Platinum-free Chemotherapy in the New Era of Immunotherapy: A Phase II Study of Camrelizumab Combined with Apatinib and Albumin Paclitaxel in Advanced Non-Squamous NSCLC (Capap-Lung).
Journal of clinical oncology（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要